SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Published Date: 13 Mar 2023

Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...

Read Full News

Latest News

Accurate and Timely Diagnosis of Endometriosis

Accurate and Timely Diagnosis of Endometriosis

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Latest News

Accurate and Timely Diagnosis of Endometriosis

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

"It really pays to be very, very, very skeptical," says one expert

News All Time

GLP-1s and Muscle Loss; 'Ozempic Personality'; Acromegaly and Cancer Risk

News and commentary from the endocrinology world

Study Warns of High-Risk Group for Fatal Liver Disease

Risky drinking and obesity "contribute synergistically" to rising rates of liver disease, death

'Ozempic Personality': Is Emotional Flattening Another Side Effect of GLP-1s?

Some patients have reported 'a dulled response' to sources of pleasure beyond food

GLP-1 Pill Spurred New Scripts; 'Food Noise' Phenomenon; Diabetes and Dementia

News and commentary from the endocrinology world

Can Endoscopic Procedure Slow Post-GLP-1 Weight Rebound?

In pilot trial, duodenal mucosal resurfacing shows signal of benefit

FDA Intensifies Crackdown on GLP-1 Compounding

Agency proposal would exclude semaglutide, tirzepatide, and liraglutide from 503B bulks list

GLP-1 Drug Improved Motivation in Major Depressive Disorder

Findings have implications for treating neuropsychiatric disorders involving reward dysfunction

Vision-Threatening Forms of Diabetic Retinal Disease Have Plummeted

Better diabetes medications, better screening, older age at onset of DRD influence 20-year trend

Racial Differences Persist for Menopause Hormone Therapy Prescriptions

Black women more likely to receive off-label meds; Asian women more apt to get no pharma at all

Center Providing Uterus Transplants Reports More Live Births

Findings could help in counseling patients and setting expectations, researchers say

Sharp Drop in Bariatric Surgery; Plea to Protect Research; How to Prescribe Exercise

News and commentary from the endocrinology world

Game-Changer? Wegovy Cuts Heavy Drinking in Alcohol Addiction Trial

Findings come amid growing off-label prescribing of GLP-1 drugs for addiction

IL-6 Inhibitor Shows Promise in Diabetic Macular Edema

Adding vamikibart to VEGF inhibition improved visual acuity and retinal anatomy

A New Medicare Option for Weight Loss Drugs: What Doctors Should Know

New benefit comes with caveats, particularly around clinical guidelines

Transcranial Stimulation for ASD; Hospital Consultants Worth the Money?

Also in TTHealthWatch: Who benefits most from weight loss interventions?

Oral Agent for Diabetic Macular Edema Misses Mark but Still Shows Promise

— No overall change in retinal thickening with tonabersat but thicker retinas appeared to benefit

Recommended News For You

HER3 Antibody Drug Conjugate Shows Promise in NSCLC

Researchers investigate risk of developing multiple primary cancers after surviving bowel cancer

AI tool identifies women at high risk of interval breast cancer

Adjuvant Belzutifan Combo Is ‘Practice Changing’ in RCC

Researchers use AI to monitor side effects of chemotherapy and support families dealing with pediatric cancer.

In Sickle Cell Disease, Lovo-Cel is "Life-Changing, Transformative.".

A new way to measure suicide risk?

Recommended Articles For You

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond 

A Mural of Thrombus: Unlocking the Power of Art to Combat Cardiovascular Disease 

Navigating the Stages of Thyroid Cancer: A Guide for Patients 

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Risk of a second cancer after early breast cancer is low, say new findings

2.

Atezolizumab Consolidation Impresses in High-Risk DLBCL

3.

WHO launches plan for free child cancer medicines

4.

Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

5.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

1.

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances

2.

Exploring New Solutions for MCV Low: Unlocking the Potential for Improved Health

3.

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine

4.

Exploring the Potential of Bendamustine in Cancer Treatment

5.

The Dark Side of Melanoma: Uncovering the Risk Factors and Prevention Strategies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

2.

Role of Nimotuzumab in Management of Nasopharyngeal Cancer

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

5.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot